Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maki Ueyama"'
Autor:
Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji, Alice Chu, Heather Falvey, Ru Han, Maki Ueyama, Yoshie Onishi
Publikováno v:
International Journal of Ophthalmology, Vol 15, Iss 6, Pp 954-961 (2022)
AIM: To evaluate the cost-utility of iStent inject® with cataract surgery vs cataract surgery alone in patients with mild-to-moderate primary open angle glaucoma (POAG) in the Japanese setting from a public payer's perspective. METHODS: A Markov mod
Externí odkaz:
https://doaj.org/article/7387769dbc3d43de93801b912b7a7e02
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Introduction: Pneumococcal diseases (PDs) are among the leading causes of mortality and morbidity worldwide. However, the evidence on epidemiology, health economic, and patient-reported outcomes has not been systematically reviewed and published in J
Externí odkaz:
https://doaj.org/article/8959ebd635fe4a44bf0e34b3d206c98e
Autor:
Florence Joulain, Yurie Taguchi, Ichiro Arakawa, Hisako Matsumoto, Masanori Miyata, Maki Ueyama, Yuji Tohda
Background: Asthma is a common, chronic inflammatory airway disorder, with up to 1,177,000 people receiving asthma treatment in Japan. Dupilumab is a first-in-class, monoclonal antibody for the treatment of atopic diseases, including persistent asthm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6322ca0aac2cb127b8393858eb4f4b0f
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 26(6)
Background The cost of treating Clostridioides difficile infection (CDI), particularly recurrent disease, is high. In clinical trials, fidaxomicin has been associated with significantly lower recurrence rates and higher sustained cure rates versus va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e26f1b2e640f79ae7164d523105fe68
https://pubmed.ncbi.nlm.nih.gov/32165072
https://pubmed.ncbi.nlm.nih.gov/32165072